Abstract
Reduction of venous thromboembolic events in COVID-19 patients: Which role for IL-6 antagonists?
Full Text
Sign-in/Register to access full text options
Published version (Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have